22 March 2017

SIGVARIS Launches Revolutionary Compression Measurement System for Inelastic Wraps Giving Patients More Precise Care

SIGVARIS is pleased to announce that patent pending ACCUTAB is now available in the market. This initial pressure measurement system provides clinicians with the ability to prescribe a compression level for inelastic wraps.

SIGVARIS Launches Revolutionary Compression Measurement System for Inelastic Wraps Giving Patients More Precise Care

MONTREAL, Canada (April 3, 2017) – SIGVARIS now offers three inelastic compression wraps that include a one-of-a-kind initial pressure measurement system. This new system not only allows clinicians to prescribe a compression level for their patients, but also allows patients to easily set the correct initial compression level as 20–30mmHg, 30–40mmHg or 40–50mmHg when they put the garment on.

“This product enhancement is going to change the market for inelastic wraps and finally give clinicians the confidence that patients will be able to accurately set their garment to the correct compression level at home,” said Scot Dubé, president and CEO for SIGVARIS North America.

“This concept is truly revolutionary for inelastic compression wraps and is creating a new standard of care for patients who use inelastic compression wraps daily,” Dubé added.

The new ACCUTABTM system (with patent pending) works exclusively with COMPREFLEX(BK), COMPREFLEX LITE and COMPREFLEX NF (no-foot option) and now comes standard with these garments. Color pressure ranges are clearly marked for ease of use and the tab can also be trimmed, so that patients can set the pressure in place by feel rather than sight, making it easy to use for patients who have a limited range of motion.

“Most inelastic brands don’t offer a way to measure compression,” said Keith Hoffman, director of operations for inelastic compression for SIGVARIS North America. “We spent a lot of time working with patients and clinicians to ensure this will be the easiest, most accurate device for measuring initial compression. Accuracy is important for better clinical outcomes, and an easy patient experience means higher rates of compliance.”

To learn more about SIGVARIS’ complete line of compression products, including inelastic compression wraps for patients with wounds, severe edema and lymphedema, please visit: www.sigvaris.ca


SIGVARIS® North America is part of an internationally active medical device group headquartered in Winterthur, Switzerland that focuses on the development, production and distribution of medical compression garments, including hosiery, socks and inelastic compression. With distribution in more than 70 countries on six continents, SIGVARIS is recognized as a global industry leader in compression therapy for the management of chronic venous disorders, lymphedema and wound care. This family-owned company is more than 150 years old. For more information on our company and products, please visit www.sigvaris.ca. SIGVARIS is a registered trademark of SIGVARIS AG, CH-9014 St. Gallen/Switzerland and in many countries, worldwide.